Neurocrine Biosciences, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
NBIX Nasdaq 2834 www.neurocrine.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Neurocrine Biosciences, Inc.

Neurocrine Biosciences Presents New Clinically Meaningful Response Data on Treatment of Tardive Dyskinesia, Reinforcing the Efficacy of INGREZZA® (valbenazine) Capsules Across a Broad Range of Patients - Jun 8th, 2026 2:05 pm
Neurocrine Biosciences Presents New Data Highlighting Functional and Socio-emotional Improvements with INGREZZA® (valbenazine) Capsules in Individuals with Tardive Dyskinesia and Intellectual and Developmental Disabilities - Jun 8th, 2026 6:30 am
Assessing Neurocrine Biosciences (NBIX) Valuation After Recent Share Price Momentum - Jun 4th, 2026 10:50 pm
RBC Capital Raises its Price Target on Neurocrine Biosciences (NBIX) - Jun 4th, 2026 10:49 am
Dow Jones Futures Rise, But Broadcom, CrowdStrike, Ciena Hit Techs; SpaceX IPO Price Target Set - Jun 4th, 2026 6:06 am
Neurocrine Biosciences to Present New Two‑Year CRENESSITY® (crinecerfont) Data on Key Clinical and Patient‑Reported Outcome Measures at ENDO 2026 - Jun 3rd, 2026 6:30 am
Meta Platforms upgraded, Okta downgraded: Wall Street's top analyst calls - Jun 2nd, 2026 7:43 am
Centene, Deckers and 14 Other ‘Dividend Hopefuls’ - Jun 1st, 2026 11:30 pm
Neurocrine Biosciences Should See More Upside on Crenessity Growth, RBC Says - May 29th, 2026 10:21 am
Neurocrine Biosciences to Present at Upcoming Investor Conferences in June - May 26th, 2026 2:01 pm
US High Growth Tech Stocks To Watch Now - May 26th, 2026 5:38 am
Bernstein Initiates Coverage of Neurocrine Biosciences (NBIX) with Outperform - May 25th, 2026 5:49 pm
Will New Real-World INGREZZA (valbenazine) Data in Mild TD Change Neurocrine Biosciences' (NBIX) Narrative - May 21st, 2026 2:10 am
A Look At Neurocrine Biosciences (NBIX) Valuation As New INGREZZA Real World Data Gains Attention - May 20th, 2026 11:13 pm
Neurocrine Biosciences Hits New Highs On Earnings Surge - May 20th, 2026 10:39 am
Bausch Health Announces 2026 Annual Meeting of Shareholder Results - May 19th, 2026 2:15 pm
Neurocrine Biosciences Presents Real-World Data Highlighting Functional Impact of Mild Tardive Dyskinesia Severity and Improvement with INGREZZA® (valbenazine) Capsules - May 18th, 2026 2:05 pm
Neurocrine Biosciences Completes Acquisition of Soleno Therapeutics - May 18th, 2026 6:46 am
CrowdStrike Leads This Group Of Four Stocks To New Highs - May 15th, 2026 11:28 am
Soleno Merger With Neurocrine Puts Profitability And Valuation In Focus - May 10th, 2026 9:14 pm